The Rising Concern of the SARS-CoV-2 Omicron Subvariants and Their Hybrids
H. Shafeeq Ahmed
Citation Information :
Ahmed HS. The Rising Concern of the SARS-CoV-2 Omicron Subvariants and Their Hybrids. Indian J Respir Care 2022; 11 (3):283-284.
Meo SA, Meo AS, Al-Jassir FF, Klonoff DC. Omicron SARS-CoV-2 new variant: Global prevalence and biological and clinical characteristics. Eur Rev Med Pharmacol Sci 2021;25:8012-8.
Statement on Omicron sublineage BA.2. Available from: https://www. who.int/news/item/22-02-2022-statement-on-omicron-sublineage-ba.
[Last accessed on 2022 Apr 03].
Chen J, Wei GW. Omicron BA.2 (B.1.1.529.2): High potential to becoming the next dominating variant. Res Sq 2022:s3-1362445.
Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. COVID-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med 2022;386:1532-46.
Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, et al. Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant. N Engl J Med 2021;385:585-94.
Andrews N, Tessier E, Stowe J, Gower C, Kirsebom F, Simmons R, et al. Duration of protection against mild and severe disease by COVID-19 vaccines. N Engl J Med 2022;386:340-50.
Goutam Mukherjee A, Ramesh Wanjari U, Murali R, Chaudhary U, Renu K, Madhyastha H, et al. Omicron variant infection and the associated immunological scenario. Immunobiology 2022;227:152222.
